Logo image of BRBR

BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis

NYSE:BRBR - New York Stock Exchange, Inc. - US07831C1036 - Common Stock - Currency: USD

57.94  -0.35 (-0.6%)

After market: 57.94 0 (0%)

Fundamental Rating

5

BRBR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. While BRBR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. BRBR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BRBR had positive earnings in the past year.
BRBR had a positive operating cash flow in the past year.
In the past 5 years BRBR has always been profitable.
BRBR had a positive operating cash flow in each of the past 5 years.
BRBR Yearly Net Income VS EBIT VS OCF VS FCFBRBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With an excellent Return On Assets value of 29.66%, BRBR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 46.22%, BRBR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
BRBR had an Average Return On Invested Capital over the past 3 years of 38.65%. This is significantly above the industry average of 15.14%.
The 3 year average ROIC (38.65%) for BRBR is below the current ROIC(46.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 29.66%
ROE N/A
ROIC 46.22%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
BRBR Yearly ROA, ROE, ROICBRBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin of BRBR (12.82%) is better than 91.43% of its industry peers.
In the last couple of years the Profit Margin of BRBR has declined.
BRBR has a better Operating Margin (19.80%) than 94.29% of its industry peers.
BRBR's Operating Margin has been stable in the last couple of years.
BRBR has a Gross Margin of 35.78%. This is in the lower half of the industry: BRBR underperforms 77.14% of its industry peers.
BRBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.8%
PM (TTM) 12.82%
GM 35.78%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
BRBR Yearly Profit, Operating, Gross MarginsBRBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

BRBR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, BRBR has less shares outstanding
BRBR has more shares outstanding than it did 5 years ago.
BRBR has a better debt/assets ratio than last year.
BRBR Yearly Shares OutstandingBRBR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRBR Yearly Total Debt VS Total AssetsBRBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.40 indicates that BRBR is not in any danger for bankruptcy at the moment.
BRBR has a Altman-Z score of 8.40. This is amongst the best in the industry. BRBR outperforms 85.71% of its industry peers.
BRBR has a debt to FCF ratio of 6.07. This is a slightly negative value and a sign of low solvency as BRBR would need 6.07 years to pay back of all of its debts.
The Debt to FCF ratio of BRBR (6.07) is better than 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.07
Altman-Z 8.4
ROIC/WACC5.32
WACC8.68%
BRBR Yearly LT Debt VS Equity VS FCFBRBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

2.3 Liquidity

BRBR has a Current Ratio of 2.92. This indicates that BRBR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BRBR (2.92) is better than 71.43% of its industry peers.
A Quick Ratio of 1.34 indicates that BRBR should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.34, BRBR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 1.34
BRBR Yearly Current Assets VS Current LiabilitesBRBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

BRBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.52%, which is quite impressive.
Measured over the past years, BRBR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.29% on average per year.
Looking at the last year, BRBR shows a quite strong growth in Revenue. The Revenue has grown by 18.91% in the last year.
The Revenue has been growing by 18.50% on average over the past years. This is quite good.
EPS 1Y (TTM)32.52%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%17.78%
Revenue 1Y (TTM)18.91%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%18.88%

3.2 Future

Based on estimates for the next years, BRBR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.99% on average per year.
BRBR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.98% yearly.
EPS Next Y16.16%
EPS Next 2Y15.43%
EPS Next 3Y15.6%
EPS Next 5Y13.99%
Revenue Next Year16%
Revenue Next 2Y13.51%
Revenue Next 3Y12.44%
Revenue Next 5Y9.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRBR Yearly Revenue VS EstimatesBRBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BRBR Yearly EPS VS EstimatesBRBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

BRBR is valuated quite expensively with a Price/Earnings ratio of 26.82.
The rest of the industry has a similar Price/Earnings ratio as BRBR.
When comparing the Price/Earnings ratio of BRBR to the average of the S&P500 Index (27.30), we can say BRBR is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 22.53, the valuation of BRBR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, BRBR is valued a bit cheaper than the industry average as 62.86% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.76. BRBR is around the same levels.
Industry RankSector Rank
PE 26.82
Fwd PE 22.53
BRBR Price Earnings VS Forward Price EarningsBRBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BRBR's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as BRBR.
Industry RankSector Rank
P/FCF 46.84
EV/EBITDA 18.4
BRBR Per share dataBRBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BRBR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BRBR has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BRBR's earnings are expected to grow with 15.60% in the coming years.
PEG (NY)1.66
PEG (5Y)N/A
EPS Next 2Y15.43%
EPS Next 3Y15.6%

0

5. Dividend

5.1 Amount

BRBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BELLRING BRANDS INC

NYSE:BRBR (7/11/2025, 8:04:01 PM)

After market: 57.94 0 (0%)

57.94

-0.35 (-0.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners101.41%
Inst Owner Change-0.02%
Ins Owners1.29%
Ins Owner Change6.85%
Market Cap7.36B
Analysts81.82
Price Target80.58 (39.07%)
Short Float %3.19%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.06%
Min EPS beat(2)-0.84%
Max EPS beat(2)18.96%
EPS beat(4)3
Avg EPS beat(4)9.41%
Min EPS beat(4)-0.84%
Max EPS beat(4)19.07%
EPS beat(8)7
Avg EPS beat(8)10.43%
EPS beat(12)11
Avg EPS beat(12)10.25%
EPS beat(16)14
Avg EPS beat(16)13.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)-0.33%
Revenue beat(4)1
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)1.64%
Revenue beat(8)4
Avg Revenue beat(8)1.03%
Revenue beat(12)6
Avg Revenue beat(12)0.06%
Revenue beat(16)8
Avg Revenue beat(16)0.68%
PT rev (1m)-6.78%
PT rev (3m)-7.99%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)-13.72%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.2%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-8.83%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 26.82
Fwd PE 22.53
P/S 3.36
P/FCF 46.84
P/OCF 45.9
P/B N/A
P/tB N/A
EV/EBITDA 18.4
EPS(TTM)2.16
EY3.73%
EPS(NY)2.57
Fwd EY4.44%
FCF(TTM)1.24
FCFY2.13%
OCF(TTM)1.26
OCFY2.18%
SpS17.26
BVpS-2
TBVpS-3.57
PEG (NY)1.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 29.66%
ROE N/A
ROCE 61.65%
ROIC 46.22%
ROICexc 48.14%
ROICexgc 68.26%
OM 19.8%
PM (TTM) 12.82%
GM 35.78%
FCFM 7.17%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score6
Asset Turnover2.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.07
Debt/EBITDA 2.11
Cap/Depr 17.3%
Cap/Sales 0.15%
Interest Coverage 250
Cash Conversion 35.42%
Profit Quality 55.91%
Current Ratio 2.92
Quick Ratio 1.34
Altman-Z 8.4
F-Score6
WACC8.68%
ROIC/WACC5.32
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%17.78%
EPS Next Y16.16%
EPS Next 2Y15.43%
EPS Next 3Y15.6%
EPS Next 5Y13.99%
Revenue 1Y (TTM)18.91%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%18.88%
Revenue Next Year16%
Revenue Next 2Y13.51%
Revenue Next 3Y12.44%
Revenue Next 5Y9.98%
EBIT growth 1Y36.47%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year24.08%
EBIT Next 3Y15.63%
EBIT Next 5Y12.76%
FCF growth 1Y598.22%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y576.37%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%